KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $631.4 million.

  • Oscar Health's Net Cash Flow rose 9780.38% to $631.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year increase of 46760.86%. This contributed to the annual value of $1.3 billion for FY2025, which is 46760.86% up from last year.
  • As of Q4 2025, Oscar Health's Net Cash Flow stood at $631.4 million, which was up 9780.38% from -$450.5 million recorded in Q3 2025.
  • Over the past 5 years, Oscar Health's Net Cash Flow peaked at $1.5 billion during Q1 2021, and registered a low of -$1.1 billion during Q3 2024.
  • For the 5-year period, Oscar Health's Net Cash Flow averaged around $98.1 million, with its median value being $253.2 million (2022).
  • Per our database at Business Quant, Oscar Health's Net Cash Flow soared by 86571.21% in 2021 and then crashed by 210890.46% in 2022.
  • Over the past 5 years, Oscar Health's Net Cash Flow (Quarter) stood at $27.6 million in 2021, then tumbled by 2108.9% to -$554.8 million in 2022, then skyrocketed by 184.8% to $470.4 million in 2023, then plummeted by 32.15% to $319.2 million in 2024, then soared by 97.8% to $631.4 million in 2025.
  • Its Net Cash Flow stands at $631.4 million for Q4 2025, versus -$450.5 million for Q3 2025 and $363.0 million for Q2 2025.